Drug Topics April 29, 2024
Check out these important FDA updates from the month of April 2024.
FDA Approves Iloperidone for Acute Treatment of Manic, Mixed Episodes in Bipolar I
The FDA approved iloperidone tablets (Fanapt) for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults. The atypical antipsychotic agent was initially approved in 2009 for the acute treatment of schizophrenia. loperidone includes a boxed warning for increased mortality in older patients with dementia-related psychosis.
FDA Approves Antibiotic Ceftobiprole Medocaril for Injection for 3 Indications
The FDA approved antibiotic ceftobiprole medocaril sodium for injection (Zevtera) for 3 indications: the treatment of adults with Staphylococcus aureus bacteremia (SAB), including right-sided infective endocarditis; the treatment of adults with acute bacterial skin...
Today's Sponsors
Today's Sponsor